Fulgent Genetics (FLGT) Stock Statistics & Valuation Metrics
Total Valuation
Fulgent Genetics has a market cap or net worth of MXN 10.66B. The enterprise value is MXN 321.60M.
- Market Cap
- MXN 10.66B
- Enterprise Value
- MXN 321.60M
Share Statistics
Fulgent Genetics has 27,515,293 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 27,515,293
- Owned by Insiders
- 40.01%
- Owned by Institutions
- 1.23%
Financial Efficiency
Fulgent Genetics’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -7.09%.
- Return on Equity (ROE)
- -0.05
- Return on Assets (ROA)
- -0.05
- Return on Invested Capital (ROIC)
- -7.09%
- Return on Capital Employed (ROCE)
- -0.08
- Revenue Per Employee
- 245.38K
- Profits Per Employee
- -46.02K
- Employee Count
- 1,315
- Asset Turnover
- 0.27
- Inventory Turnover
- 18.09
Valuation Ratios
The current PE Ratio of Fulgent Genetics is -7.31. Fulgent Genetics’s PEG ratio is 0.13.
- PE Ratio
- -7.31
- PS Ratio
- 1.75
- PB Ratio
- 0.58
- Price to FCF
- -5.47
- Price to Operating Cash Flow
- -6.90
- PEG Ratio
- 0.13
Income Statement
In the last 12 months, Fulgent Genetics had revenue of 322.67M and earned -60.51M in profits. Earnings per share was -1.97.
- Revenue
- 322.67M
- Gross Profit
- 130.88M
- Operating Income
- -91.10M
- Pretax Income
- -70.03M
- Net Income
- -60.51M
- EBITDA
- -45.83M
- Earnings Per Share (EPS)
- -1.97
Cash Flow
In the last 12 months, operating cash flow was -83.70M and capital expenditures -20.09M, giving a free cash flow of -103.79M billion.
- Operating Cash Flow
- -83.70M
- Free Cash Flow
- -103.79M
- Free Cash Flow per Share
- -3.71
Dividends & Yields
Fulgent Genetics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -18.29%
- Earnings Yield
- -14.61%
Stock Price Statistics
- Beta
- 0.48
- 52-Week Price Change
- -8.91%
- 50-Day Moving Average
- 348.56
- 200-Day Moving Average
- 329.33
- Relative Strength Index (RSI)
- 54.35
- Average Volume (3m)
- 16
Important Dates
Fulgent Genetics upcoming earnings date is Nov 05, 2026, After Close (Not Confirmed).
- Last Earnings Date
- Jul 30, 2026
- Next Earnings Date
- Nov 05, 2026
- Ex-Dividend Date
- ―
Financial Position
Fulgent Genetics as a current ratio of 6.48, with Debt / Equity ratio of 0.69%
- Current Ratio
- 6.48
- Quick Ratio
- 6.35
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.93
- Interest Coverage Ratio
- -1214.61
Taxes
In the past 12 months, Fulgent Genetics has paid -8.39M in taxes.
- Income Tax
- -8.39M
- Effective Tax Rate
- 0.12
Enterprise Valuation
Fulgent Genetics EV to EBITDA ratio is -8.47, with an EV/FCF ratio of -5.30.
- EV to Sales
- 1.70
- EV to EBITDA
- -8.47
- EV to Free Cash Flow
- -5.30
- EV to Operating Cash Flow
- -6.58
Balance Sheet
Fulgent Genetics has MXN 257.03M in cash and marketable securities with MXN 9.42M in debt, giving a net cash position of MXN 247.61M billion.
- Cash & Marketable Securities
- MXN 257.03M
- Total Debt
- MXN 9.42M
- Net Cash
- MXN 247.61M
- Net Cash Per Share
- MXN 9.00
- Tangible Book Value Per Share
- MXN 28.31
Margins
Gross margin is 35.58%, with operating margin of -37.08%, and net profit margin of -26.05%.
- Gross Margin
- 35.58%
- Operating Margin
- -37.08%
- Pretax Margin
- -28.12%
- Net Profit Margin
- -26.05%
- EBITDA Margin
- -20.07%
- EBIT Margin
- -28.05%
Analyst Forecast
The average price target for Fulgent Genetics is MXN 358.76, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- MXN 358.76
- Price Target Upside
- 4.64% Downside
- Analyst Consensus
- Neutral
- Analyst Count
- 1
- Revenue Growth Forecast
- -2.67%
- EPS Growth Forecast
- -53.68%
Scores
- Smart Score
- 4
- AI Score
- ―